1-6 of 6
Paolo Lopedote
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Acalabrutinib, Umbralisib and Ublituximab Regimen (AU2) Demonstrates High Response Rate and Undetectable Molecular Minimal Residual Disease (MRD) in Patients (pts) with De Novo Mantle Cell Lymphoma (MCL)

Paolo Lopedote, Geoffrey Shouse, Alexandra Muir, Carly Rolender, Peter Sportelli, Hari Miskin, Lu Chen, Tycel Phillips, Alexey Danilov
Journal: Blood
Blood (2024) 144 (Supplement 1): 1633.
https://doi.org/10.1182/blood-2024-200963
Published: 2024
Journal Articles

Prevalence, Characteristics, and Clinical Impact of Clonal Hematopoiesis of Indeterminate Potential in AL Amyloidosis

Paolo Lopedote, Alfredo Marchetti, Benjamin Evans, Tianzeng Chen, Maria Moscvin, Niccolò Bolli, Giada Bianchi
Journal: Blood
Blood (2023) 142 (Supplement 1): 2029.
https://doi.org/10.1182/blood-2023-190905
Published: 2023
Journal Articles

Screening Cerebrospinal Fluid for Aggressive B-Cell Lymphoma: Significance of Clonal Populations Found with 8-Color Flow Cytometry

Carrie I Ho, Paolo Lopedote, Olivia Lin, Jonathan R Fromm, Ajay K Gopal, Filippo Milano, Stephen D Smith
Journal: Blood
Blood (2023) 142 (Supplement 1): 6263.
https://doi.org/10.1182/blood-2023-181450
Published: 2023
Journal Articles

Clinical Relevance of MYD88 L265P Mutation and Interleukin-10 Level in Cerebrospinal Fluid of Patients with Both Newly Diagnosed and Relapsed Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System

Andres JM Ferreri, MD, Teresa Calimeri, MD PhD, Paolo Lopedote, MD, Ilaria Francaviglia, Rita Daverio, MD, Chiara Iacona, Cristina Belloni, BD, Sara Steffanoni, MD, Elena Anghileri, MD, Angelo Diffidenti, Annamaria Finardi, BD, Filipppo Gagliardi, MD, Nicoletta Anzalone, MD, Alessandro Nonis, Roberto Furlan, MD, Piera Angelillo, MD, Marianna Sassone, MD, Daniela De Lorenzo, BD, Maria Rosa Terreni, MD, Marco Foppoli, Elena Guggiari, MD, Vittoria Tarantino, MD, Marika Eoli, MD, Fabio Ciceri, MD, Claudio Doglioni, Massimo Locatelli, MD, Maurilio Ponzoni, MD, Maria Giulia Cangi
Journal: Blood
Blood (2019) 134 (Supplement_1): 4114.
https://doi.org/10.1182/blood-2019-128298
Published: 2019
Journal Articles

R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma

Clinical Trials & Observations
Andrés J. M. Ferreri, Teresa Calimeri, Gian Marco Conte, Dario Cattaneo, Federico Fallanca, Maurilio Ponzoni, Eloise Scarano, Flavio Curnis, Alessandro Nonis, Paolo Lopedote, Giovanni Citterio, Letterio S. Politi, Marco Foppoli, Stefania Girlanda, Marianna Sassone, Salvatore Perrone, Caterina Cecchetti, Fabio Ciceri, Claudio Bordignon, Angelo Corti, Nicoletta Anzalone
Journal: Blood
Blood (2019) 134 (3): 252–262.
https://doi.org/10.1182/blood.2019000633
Published: 2019
Includes: Supplemental data
Journal Articles

R-CHOP Preceded By Engineered Tumor Necrosis Factor (TNF) in Patients with Relapsed or Refractory (r/r) Primary CNS Lymphoma (PCNSL): Results of Antitumor Activity, Safety and Blood-Brain Barrier (BBB) Permeabilization in the "Ingrid" Phase II Trial

Andres JM Ferreri, MD, Teresa Calimeri, MDPhD, Gian Marco Conte, MD, Dario Cattaneo, MD, Federico Fallanca, MD, Maurilio Ponzoni, MD, Eloise Scarano, Marianna Sassone, MD, Salvatore Perrone, MD, Caterina Cecchetti, MD, Paolo Lopedote, MD, Fiorella Ilariucci, Roberta Rudà, MD, Emanuele Angelucci, MD, Carlo Visco, Francesco Pisani, MD, Alberto Fabbri, MD, Luigi Petrucci, MD, Marco Bregni, MD, Dario Marino, MDPhD, Guido Gini, MD, Fabio Ciceri, MD, Angelo Corti, MD, Nicoletta Anzalone, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1687.
https://doi.org/10.1182/blood-2018-99-118507
Published: 2018